GSE182382 Mettl3 Alkbh5 knockdown 1 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE182382_Mettl3_Alkbh5 knockdown_1_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE182382_Mettl3_Alkbh5 knockdown_1_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE182382_Mettl3_Alkbh5 knockdown_1_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE182382_Mettl3_Alkbh5 knockdown_1_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

H2B clustered histone 8

Gene

H19 imprinted maternally expressed transcript

Gene

POU class 3 homeobox 3

Gene

MIR663A host gene

Gene

RNA component of 7SK nuclear ribonucleoprotein

Gene

ZFHX3 antisense RNA 1

Gene

RNA component of signal recognition particle 7SL2

Gene

RNA component of signal recognition particle 7SL1

Gene

RNA, 5.8S ribosomal N1

Gene

RNA, 5.8S ribosomal N3

  • Gene

    H2B clustered histone 8


  • Gene

    H19 imprinted maternally expressed transcript


  • Gene

    POU class 3 homeobox 3



  • Gene

    RNA component of 7SK nuclear ribonucleoprotein


  • Gene

    ZFHX3 antisense RNA 1


  • Gene

    RNA component of signal recognition particle 7SL2


  • Gene

    RNA component of signal recognition particle 7SL1


  • Gene

    RNA, 5.8S ribosomal N1


  • Gene

    RNA, 5.8S ribosomal N3

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.